Orally administrable formulation
View Patent ↗An orally administrable chewing gum formulation is provided comprising a pharmaceutically acceptable gum base and particles of a pharmaceutical agent ranging in size from about 50 to about 2000 μm, wherein the formulation comprises about 0.5-30% by wt of the pharmaceutical agent particles. A liquid formulation comprising particles of a pharmaceutical agent is also provided.
1. An aqueous-based oral liquid formulation comprising a solvent comprising water, alcohol and propylene glycol and/or polyethylene glycol in an amount in the range of about 60-99% by wt, wherein the formulation comprises up to 40% by wt water, up to 65% by wt alcohol and up to 50% by wt propylene glycol and/or polyethylene glycol combined with pharmaceutical agent-containing particles of plant material in an amount in the range of about 1-40% by wt, wherein the pharmaceutical agent is selected from the group consisting of cannabinoids, cannabinoid derivatives, terpenes and mixtures thereof, and at least 50% by wt of the particles range in size from about 50 to about 2000 μm.
2. The formulation of claim 1 , wherein the pharmaceutical agent is selected form the group consisting of cannabidiol (CBD), cannabidiol acid (CBDA), cannabinol (CBN), cannabigerol (CBG), cannabigerol acid (CBGA), cannabidivarin (CBDV), cannabidivarin acid (CBDVA), cannabinovarin (CBNV), cannabigerovarin (CBGV), cannabichromene (CBC), a naphthoylindole, a phenylacetylindole, a benzoylindole, a cyclohexylphenole, delta-9 tetrahydrocannabinol (THC or dronabinol), delta-8 tetrahydrocannabinol (D8-THC), tetrahydrocannabinol acid (THCA), tetrahydrocannabivarin (THCV), tetrahydrocannabivarin acid (THCVA), nabilone, rimonabant (SR141716)TWH-018, JWH-073, CP-55940, dimethylheptylpyran, HU-210, HU-331, SR144528, WIN 55,212-2, JWH-133, levonantradol, and AM-2201.
3. The formulation of claim 2 , wherein the pharmaceutical agent is CBD, THC or a combination thereof.
4. The formulation of claim 1 , wherein at least 75% by weight of the pharmaceutical particles have a size in the range of 300 to 750 μm.
5. The formulation of claim 1 , wherein the plant material is Cannabis leaves.
6. The formulation of claim 1 , wherein the pharmaceutical agent-containing particles comprise a water content of at least about 10%.
7. The formulation of claim 1 , wherein the pharmaceutical agent-containing particles comprise a water content of 10-50%.
8. The formulation of claim 1 , wherein the solvent comprises about 29.9% water by wt, about 50% alcohol by wt and a cosolvent comprising propylene glycol, polyethylene glycol or a combination thereof in an amount of from about 12.5% by wt.
9. The formulation of claim 1 , comprising 7.5% by wt pharmaceutical agent-containing particles and solvent in an amount of greater than 90% by wt.
10. The formulation of claim 1 , additionally comprising one or more of a sweetener, a colorant, a flavouring agent, or an anti-microbial agent.